Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?

OBJECTIVES The treatment of bone and joint infections is challenging due to the presence of bacterial biofilm and the increasing emergence of multiresistant strains. BAG-S53P4 is a bone substitute that is characterized by osteoconductive and antimicrobial properties. The aim of this study was to assess the effectiveness of BAG-S53P4 against biofilm produced in vitro by multiresistant bacterial strains. METHODS Multiresistant Staphylococcus epidermidis, Acinetobacter baumannii and Klebsiella pneumoniae isolated from bone and joint infections were used in this study. Titanium discs covered by bacterial biofilm were incubated with BAG-S53P4 or inert glass as a control. The amount of biofilm on each titanium disc was evaluated after 48 h of incubation by means of confocal laser scanning microscopy. RESULTS Significantly lower total biomass volumes were observed for all strains after treatment with BAG-S53P4 when compared with controls. Moreover, the percentage of dead cells was significantly higher in treated samples than in controls for all the tested strains. CONCLUSIONS BAG-S53P4 is able to reduce the biofilm produced by multiresistant S. epidermidis, A. baumannii and K. pneumoniae on titanium substrates in vitro, probably by interfering with cell viability. Owing to its osteoconductive, antibacterial and antibiofilm properties, the use of BAG-S53P4 may be a successful strategy for the treatment of bone and prosthetic joint infections.

[1]  C. Ammann,et al.  BAG‐S53P4 as an additive to bone allografts: A laboratory study using an uniaxial compression test , 2015 .

[2]  L. Drago,et al.  Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains. , 2015, Future microbiology.

[3]  C. Lindqvist,et al.  The use of anatomically drop-shaped bioactive glass S53P4 implants in the reconstruction of orbital floor fractures--A prospective long-term follow-up study. , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[4]  R. Hancock,et al.  Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies. , 2014, Journal of biotechnology.

[5]  Aldo R Boccaccini,et al.  Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate angiogenesis in bone. , 2014, Journal of biomedical materials research. Part A.

[6]  P. Vallittu,et al.  Effect of implant design and bioactive glass coating on biomechanical properties of fiber-reinforced composite implants. , 2014, European journal of oral sciences.

[7]  L. Drago,et al.  Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material. , 2014, International journal of antimicrobial agents.

[8]  L. Drago,et al.  In vitro antibiofilm activity of bioactive glass S53P4. , 2014, Future microbiology.

[9]  A. Man,et al.  The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads. , 2014, Acta microbiologica et immunologica Hungarica.

[10]  L. Drago,et al.  A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. , 2014, The bone & joint journal.

[11]  M. Nogler,et al.  Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  L. Drago,et al.  Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study , 2013, BMC Infectious Diseases.

[13]  E. Sheehan,et al.  Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis , 2013, Irish Journal of Medical Science.

[14]  R. G. Richards,et al.  Influence of material on the development of device-associated infections. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  J. Lam,et al.  Training the Biofilm Generation—a Tribute to J. W. Costerton , 2012, Journal of bacteriology.

[16]  J. Costerton,et al.  Using biofilms as initial inocula in animal models of biofilm-related infections. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[17]  S. Kajander,et al.  Posterolateral Spondylodesis Using Bioactive Glass S53P4 and Autogenous Bone in Instrumented Unstable Lumbar Spine Burst Fractures , 2012, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[18]  P. Hyvönen,et al.  Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. , 2010, Bone.

[19]  Eveliina Munukka,et al.  Antibacterial effects and dissolution behavior of six bioactive glasses. , 2009, Journal of biomedical materials research. Part A.

[20]  M. Hupa,et al.  In situ pH within particle beds of bioactive glasses. , 2008, Acta biomaterialia.

[21]  M. V. van Loosdrecht,et al.  Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix--a modelling study. , 2005, Microbiology.

[22]  L. Baddour,et al.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices , 1985, Journal of clinical microbiology.

[23]  G. K. Badave,et al.  Biofilm Producing Multidrug Resistant Acinetobacter baumannii: An Emerging Challenge. , 2015, Journal of clinical and diagnostic research : JCDR.

[24]  M. Nogler,et al.  BAG-S53P4 as an additive to bone allografts: A laboratory study using an uniaxial compression test. , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  E. Gullichsen,et al.  Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures - a prospective randomized 11-year follow-up. , 2011, Journal of long-term effects of medical implants.

[26]  T. Peltola,et al.  Bactericidal effects of bioactive glasses on clinically important aerobic bacteria , 2008, Journal of materials science. Materials in medicine.